OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Evaluation of anti-nucleocapsid level variation to assess SARS-CoV-2 seroprevalence in a vaccinated population
Renée Bazin, Samuel Rochette, Josée Perreault, et al.
Infectious Diseases (2023) Vol. 55, Iss. 6, pp. 425-430
Closed Access | Times Cited: 7
Renée Bazin, Samuel Rochette, Josée Perreault, et al.
Infectious Diseases (2023) Vol. 55, Iss. 6, pp. 425-430
Closed Access | Times Cited: 7
Showing 7 citing articles:
Anti-SARS-CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 vaccination
Magnus Rasmussen, Ariane Neumann, Mahnaz Moghaddassi, et al.
Infectious Diseases (2025), pp. 1-11
Open Access
Magnus Rasmussen, Ariane Neumann, Mahnaz Moghaddassi, et al.
Infectious Diseases (2025), pp. 1-11
Open Access
Enhancing detection of SARS-CoV-2 re-infections using longitudinal sero-monitoring: demonstration of a methodology in a cohort of people experiencing homelessness in Toronto, Canada
Lucie Richard, Rosane Nisenbaum, Karen Colwill, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Lucie Richard, Rosane Nisenbaum, Karen Colwill, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
A Recent SARS-CoV-2 Infection Enhances Antibody-Dependent Cellular Cytotoxicity against Several Omicron Subvariants following a Fourth mRNA Vaccine Dose
Guillaume Beaudoin-Bussières, Alexandra Tauzin, Katrina Dionne, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1274-1274
Open Access | Times Cited: 8
Guillaume Beaudoin-Bussières, Alexandra Tauzin, Katrina Dionne, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1274-1274
Open Access | Times Cited: 8
Christian Renaud, Antoine Lewin, Yves Grégoire, et al.
Vox Sanguinis (2024) Vol. 119, Iss. 6, pp. 533-540
Closed Access | Times Cited: 2
Humoral Responses Elicited after a Fifth Dose of SARS-CoV-2 mRNA Bivalent Vaccine
Alexandra Tauzin, Guillaume Beaudoin-Bussières, Mehdi Benlarbi, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1926-1926
Open Access | Times Cited: 4
Alexandra Tauzin, Guillaume Beaudoin-Bussières, Mehdi Benlarbi, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1926-1926
Open Access | Times Cited: 4
Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine
David G. Alleva, Eline A. Feitsma, Yester F. Janssen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
David G. Alleva, Eline A. Feitsma, Yester F. Janssen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Incidence of SARS-CoV-2 during the Omicron wave: Results of a longitudinal serosurvey in Québec, Canada
Antoine Lewin, Marc Germain, Renée Bazin, et al.
Can J Public Health (2024)
Closed Access
Antoine Lewin, Marc Germain, Renée Bazin, et al.
Can J Public Health (2024)
Closed Access
Anti-nucleocapsid level variation to assess SARS-CoV-2 seroprevalence: comment
Amnuay Kleebayoon, Viroj Wiwanitkit
Infectious Diseases (2023) Vol. 55, Iss. 6, pp. 446-446
Open Access
Amnuay Kleebayoon, Viroj Wiwanitkit
Infectious Diseases (2023) Vol. 55, Iss. 6, pp. 446-446
Open Access
